Skip to main content
. 2021 May 19;12:644862. doi: 10.3389/fimmu.2021.644862

Figure 3.

Figure 3

MCT4 regulated ERK1/2-NF-κB pathway. (A) Western blotting was employed to test phosphorylation of NF-κB and ERK1/2 activity in HT-29 and CaCO2 cells. (B) The total protein was collected in HT-29 and CaCO2 cells with or without α-CHCA stimulation for 1 h, and the indicated proteins was tested by immunoblotting. The ERK1/2 inhibitor U0126 and NF-κB inhibitor BAY11-7085 were used to treat CaCO2 cells with MCT4 overexpression for 48 h. Western blotting (C) and ELISA (D) were used to analyze IL-1β expression and secretion, respectively. Data represented the mean ± s.d. of three independent experiments; one-way ANOVA was performed to analyze statistical difference. ***p < 0.001.